The effect of exercise and royal jelly on liver enzymes in multiple sclerosis patients

The effect of 6 weeks of Selected Aerobic Exercise and royal jelly use on liver enzymes in patients multiple sclerosis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180612040073N3

Enrollment

Registered

2018-12-14

Start date

2018-11-22

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis. Multiple sclerosis

Interventions

Intervention 1: First intervention group: Exercise and Royal jelly Name of the used substance: Royal Jelly Capsule Chemical composition and concentration: Each capsule contains 1000 mg of Natural Roya

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Multiple sclerosis patients: Expanded Disability Status Scale (EDSS) between 0-4

Exclusion criteria

Exclusion criteria: Use of pharmaceutical supplements With cardiovascular disease

Design outcomes

Primary

Measure	Time frame
Aspartate Transaminase changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Blood Sampling.;Alanine Aminotransferase Changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Blood Sampling.;Alkaline Phosphatase Changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Blood Samling.	—

Measure

Time frame

Aspartate Transaminase changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Blood Sampling.;Alanine Aminotransferase Changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Blood Sampling.;Alkaline Phosphatase Changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Blood Samling.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Vahidian-Rezazadeh

University of Sistan and Baluchestan

vahidian@ped.usb.ac.ir+98 54 3341 6107

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026